City

Hackensack (1)

Montreal (1)

Overall Status

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

McGill University (1)

Rapa Therapeutics LLC (1)

Collaborator

Intervention

chemotherapy prior to rapa-201 therapy (1)

rapa-201 rapamycin resistant t cells (1)

taxotere, cisplatin, and 5-fu (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

gastric junction adenocarcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Solid Tumor, Breast Cancer, Small Cell and NSCLC Trial in Hackensack (RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior

Recruiting

Solid Tumor
+15 more

RAPA-201 Rapamycin Resistant T Cells
Chemotherapy Prior to RAPA-201 Therapy

Hackensack, New Jersey

Hackensack University Medical Center

Dec 23, 2021

Gastric Junction Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Montreal (Taxotere, Cisplatin, and 5-FU)

Unknown status

Gastric Junction Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma

Taxotere, Cisplatin, and 5-FU

Montreal, Quebec, Canada

McGill University

Oct 20, 2008